Abstract
Fourteen years have passed since nuclear factor-κB (NF-κB) was first shown to serve as a molecular lynchpin that links persistent infections and chronic inflammation to increased cancer risk. The young field of inflammation and cancer has now come of age, and inflammation has been recognized by the broad cancer research community as a hallmark and cause of cancer. Here, we discuss how the initial discovery of a role for NF-κB in linking inflammation and cancer led to an improved understanding of tumour-elicited inflammation and its effects on anticancer immunity.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Animals
-
Autophagy / immunology
-
Cellular Senescence / immunology
-
Chemokines / immunology
-
Cytokines / immunology
-
Female
-
Fibroblasts / immunology
-
Humans
-
Inflammation / immunology*
-
Lymphocytes / immunology
-
Male
-
Models, Immunological
-
Myeloid Cells / immunology
-
NF-kappa B / immunology*
-
Neoplasms / etiology
-
Neoplasms / immunology*
-
Neoplasms / pathology
-
Neoplastic Stem Cells / immunology
-
Signal Transduction / immunology
-
Tumor Microenvironment / immunology
Substances
-
Chemokines
-
Cytokines
-
NF-kappa B